Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Cytotherapy
|
March 31, 2021
The capacity of CD4<sup>+</sup> Vγ9Vδ2 T cells to kill cancer cells correlates with co-expression of CD56
Gitte Holmen Olofsson, Sara Ram Pedersen, Pia Aehnlich, et al.
Plos One
|
September 26, 2024
The heat shock protein 90 inhibitor RGRN-305 attenuates SARS-CoV-2 spike protein-induced inflammation in vitro but lacks effectiveness as COVID-19 treatment in mice
Hakim Ben Abdallah, Giorgia Marino, Manja Idorn, et al.
Oncoimmunology
|
November 15, 2013
Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes
Simone P Sittig, Tania Køllgaard, Kirsten Grønbæk, et al.
Oncoimmunology
|
September 18, 2018
Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model
Manja Idorn, Signe Koggersbøl Skadborg, Lauge Kellermann, et al.
Scandinavian Cardiovascular Journal : SCJ
|
June 17, 2016
Effects of liraglutide and ischemic postconditioning on myocardial salvage after I/R injury in pigs
Kathrine Ekström, Morten Dalsgaard, Kasper Iversen, et al.
Oncoimmunology
|
May 12, 2015
Spontaneous presence of FOXO3-specific T cells in cancer patients
Stine Kiaer Larsen, Shamaila Munir Ahmad, Manja Idorn, et al.
Oncoimmunology
|
April 11, 2018
Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction
Manja Idorn, Maria Olsen, Hólmfrídur Rósa Halldórsdóttir, et al.
Oncoimmunology
|
September 28, 2013
High frequency of T cells specific for cryptic epitopes in melanoma patients
Rikke Sick Andersen, Sofie Ramskov Andersen, Mads Duus Hjortsø, et al.
European Journal of Immunology
|
February 7, 2022
The presence of serum anti-SARS-CoV-2 IgA appears to protect primary health care workers from COVID-19
Viktoria Hennings, Karolina Thörn, Sofie Albinsson, et al.
Frontiers in Immunology
|
June 21, 2021
Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens
Gitte Holmen Olofsson, Manja Idorn, Ana Micaela Carnaz Simões, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Cytotherapy
|
March 31, 2021
The capacity of CD4<sup>+</sup> Vγ9Vδ2 T cells to kill cancer cells correlates with co-expression of CD56
Gitte Holmen Olofsson, Sara Ram Pedersen, Pia Aehnlich, et al.
Plos One
|
September 26, 2024
The heat shock protein 90 inhibitor RGRN-305 attenuates SARS-CoV-2 spike protein-induced inflammation in vitro but lacks effectiveness as COVID-19 treatment in mice
Hakim Ben Abdallah, Giorgia Marino, Manja Idorn, et al.
Oncoimmunology
|
November 15, 2013
Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes
Simone P Sittig, Tania Køllgaard, Kirsten Grønbæk, et al.
Oncoimmunology
|
September 18, 2018
Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model
Manja Idorn, Signe Koggersbøl Skadborg, Lauge Kellermann, et al.
Scandinavian Cardiovascular Journal : SCJ
|
June 17, 2016
Effects of liraglutide and ischemic postconditioning on myocardial salvage after I/R injury in pigs
Kathrine Ekström, Morten Dalsgaard, Kasper Iversen, et al.
Oncoimmunology
|
May 12, 2015
Spontaneous presence of FOXO3-specific T cells in cancer patients
Stine Kiaer Larsen, Shamaila Munir Ahmad, Manja Idorn, et al.
Oncoimmunology
|
April 11, 2018
Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction
Manja Idorn, Maria Olsen, Hólmfrídur Rósa Halldórsdóttir, et al.
Oncoimmunology
|
September 28, 2013
High frequency of T cells specific for cryptic epitopes in melanoma patients
Rikke Sick Andersen, Sofie Ramskov Andersen, Mads Duus Hjortsø, et al.
European Journal of Immunology
|
February 7, 2022
The presence of serum anti-SARS-CoV-2 IgA appears to protect primary health care workers from COVID-19
Viktoria Hennings, Karolina Thörn, Sofie Albinsson, et al.
Frontiers in Immunology
|
June 21, 2021
Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens
Gitte Holmen Olofsson, Manja Idorn, Ana Micaela Carnaz Simões, et al.
Page
of 5